Description
United Peptides PT-141 (Bremelanotide) is a synthetic research peptide that acts as a melanocortin receptor agonist. This 10mg vial is intended for research purposes, enabling scientists to study its effects on receptor-mediated signaling pathways, neuroendocrine responses, and melanocortin system activity.
